Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:947041.
doi: 10.1155/2012/947041. Epub 2012 Mar 11.

The Effect of Cold Ischemia Time and/or Formalin Fixation on Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Results in Breast Carcinoma

Affiliations

The Effect of Cold Ischemia Time and/or Formalin Fixation on Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Results in Breast Carcinoma

Melike Pekmezci et al. Patholog Res Int. 2012.

Abstract

Aims. To compare the results of estrogen and progesterone receptors (ER, PR), and human epidermal growth factor receptor-2 (HER2) expression status on biopsy and excision specimens and to evaluate the effect of cold ischemia time and/or formalin fixation on these biomarkers. Methods. Breast carcinomas that were diagnosed between 2007 and 2009 by core needle biopsy, and subsequently excised in our institution, were included in the study. Data regarding the tumor morphology, grade, and ER, PR, and HER2 status were retrospectively collected from the pathology reports. Results. Five out of 149 (3.4%) cases with ER-positive receptor status in the biopsy specimen became ER-negative in the subsequent excision specimen. Nine out of 126 (7.1%) cases with PR-positive receptor status in the biopsy specimen became PR-negative in the excision specimen. Receptor status change was predominantly seen in tumors with low ER and PR receptor expression. HER2 results were consistent between biopsy and excision specimens in all cases tested. Conclusions. Cold ischemia time and/or formalin fixation affect mainly ER and PR testing with low Allred scores and support the implementation of the ASCO/CAP guidelines. HER2 results, however, were not affected in our limited number of patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histology and hormone receptor staining of a case with estrogen-receptor (ER-) positive, progesterone-receptor- (PR-) positive results in biopsy and ER-negative, PR-negative results in subsequent excision. (a) Biopsy, invasive ductal carcinoma, Nottingham Grade III, hematoxylin & eosin (400x); (b) biopsy, ER (+), Allred score 3 (400x); (c) biopsy, PR (+), Allred score 3 (400x); (d) excision, invasive ductal carcinoma, Nottingham Grade III, hematoxylin & eosin (400x); (e) excision, ER (−), Allred score 0 (400x); (f) excision, PR (−), Allred score 0 (400x).

References

    1. Viale G, Regan MM, Maiorano E, et al. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1–98. Journal of Clinical Oncology. 2007;25(25):3846–3852. - PubMed
    1. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathology. 1998;11(2):155–168. - PubMed
    1. Mohsin SK, Weiss H, Havighurst T, et al. Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Modern Pathology. 2004;17(12):1545–1554. - PubMed
    1. Stendahl M, Rydén L, Nordenskjöld B, Jönsson PE, Landberg G, Jirström K. High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients. Clinical Cancer Research. 2006;12(15):4614–4618. - PubMed
    1. Abe O, Abe R, Enomoto K, et al. Tamoxifen for early breast cancer: an overview of the randomised trials. The Lancet. 1998;351(9114):1451–1467. - PubMed